by Tayler Kinner | Jan 29, 2025 | Uncategorized
Innovative Health Sciences has successfully secured the exclusive Medical Device Regulations Quality Management System Certificate from BSI (CE MDR QMS), a leading notified body, thus facilitating the introduction of the Insignis™ Infusion System into the world...
by Tayler Kinner | Aug 22, 2024 | Uncategorized
CHESTER, N.Y., Aug. 5, 2024 /PRNewswire/ — Innovative Health Sciences (“IHS” or the “Company”), a medical device company that creates state-of-the-art drug infusion solutions, announced today the expansion of its commercialization team to...
by IHS | May 8, 2022 | Uncategorized
CHESTER, N.Y. (August 26, 2021) – Innovative Health Sciences, LLC (“IHS” or the “Company”) management announced today that IHS has received FDA clearance for its Insignis™ Subcutaneous Needle Sets. This regulatory clearance allows IHS to sell and distribute its...
by IHS | Nov 12, 2021 | Uncategorized
CHESTER, N.Y. (November 12, 2021) Innovative Health Sciences, LLC (“IHS” or the “Company”) will be presenting its breakthrough versatile and low cost non-electric infusion system at Medica, a world-renowned trade fair for medical devices and medical technologies,...
by IHS | Jul 20, 2021 | Uncategorized
CHESTER, N.Y. (July 20, 2021) – Innovative Health Sciences, LLC (“IHS” or the “Company”) announced today that they have received ISO 13485 quality management system and CE mark certification for the Insignis™ Syringe Infusion System. The CE mark, abbreviated for...
